Literature DB >> 17360734

Immunolocalisation of E-cadherin and beta-catenin in human pterygium.

Satoru Kase1, Mitsuhiko Osaki, Izuru Sato, Shuji Takahashi, Katsuya Nakanishi, Kazuhiko Yoshida, Hisao Ito, Shigeaki Ohno.   

Abstract

AIM: The pterygium represents an invasion of a wing of altered ocular surface tissue into the normal cornea. The head itself is slightly elevated and white, which is the only site of firm adhesion to the globe. The mechanisms of cell proliferation and adhesion in pterygium epithelium, however, are unknown. The aim of this study was to analyse the expression of cell adhesion molecules in pterygium tissues.
METHODS: Six pterygia were surgically removed using the bare-sclera procedure, and two normal corneas and a normal bulbar conjunctiva were also obtained. Formalin-fixed, paraffin-embedded tissues were analysed by immunohistochemistry with anti-E-cadherin and beta-catenin antibodies.
RESULTS: Immunoreactivity for E-cadherin was not detected in the normal cornea and conjunctiva. In contrast, all corneal and conjunctival epithelial cells showed a weak homogeneous immunoreaction for beta-catenin on the cell membrane. In the pterygium head, the thickness was relatively marked compared with the body, and normal conjunctival and corneal epithelia. E-cadherin as well as beta-catenin was heterogeneously expressed in the cell membrane and cytoplasm of a variety of epithelial cells, whereas the expression was less marked in the body. Several epithelial cells showed intense nuclear immunoreactivity for beta-catenin. Immunoreactivity of beta-catenin, but not E-cadherin, was detected in only a few stromal cells, which were less marked than in epithelial cells.
CONCLUSION: It is suggested that E-cadherin and beta-catenin are concentrated in pterygium tissue, and are possibly involved with epithelial proliferation and adhesion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360734      PMCID: PMC1954891          DOI: 10.1136/bjo.2007.115709

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Diffuse expression of MUC 1 in metastases of renal clear cell carcinoma as a possible therapeutic target for renal cancer.

Authors:  X Leroy; S Aubert; C Ballereau; P Birembaut; N Porchet; B Gosselin; M C Copin
Journal:  Histopathology       Date:  2005-10       Impact factor: 5.087

2.  Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.

Authors:  Satoru Kase; Shuji Takahashi; Izuru Sato; Katsuya Nakanishi; Kazuhiko Yoshida; Shigeaki Ohno
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

3.  Ocular surface changes in pterygium.

Authors:  Cordelia M L Chan; Yan Ping Liu; Donald T H Tan
Journal:  Cornea       Date:  2002-01       Impact factor: 2.651

Review 4.  The role of beta-catenin in cell adhesion, signal transduction, and cancer.

Authors:  L C Bullions; A J Levine
Journal:  Curr Opin Oncol       Date:  1998-01       Impact factor: 3.645

5.  Microarray and protein analysis of human pterygium.

Authors:  Molykutty John-Aryankalayil; Nicholas Dushku; Cynthia J Jaworski; Constance A Cox; Gregory Schultz; Janine A Smith; Keri E Ramsey; Dietrich A Stephan; Kenn A Freedman; Ted W Reid; Deborah A Carper
Journal:  Mol Vis       Date:  2006-01-23       Impact factor: 2.367

Review 6.  The role of E-cadherin-catenin complex: more than an intercellular glue?

Authors:  K J Harrington; K N Syrigos; K J Harington
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

7.  Overexpression of Insulin-like growth factor-binding protein-2 in pterygium body fibroblasts.

Authors:  Abraham Solomon; Martin Grueterich; De-Quan Li; Daniel Meller; Sao-Bing Lee; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

8.  Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium.

Authors:  L Kria; A Ohira; T Amemiya
Journal:  Acta Histochem       Date:  1996-04       Impact factor: 2.479

9.  Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.

Authors:  N Kohno; S Kyoizumi; M Tanabe; T Oyama; M Vossler; M Yamakido; M Akiyama
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

Review 10.  The cadherins: cell-cell adhesion molecules controlling animal morphogenesis.

Authors:  M Takeichi
Journal:  Development       Date:  1988-04       Impact factor: 6.868

View more
  15 in total

1.  Relations between lymphangiogenesis and the size of pterygium.

Authors:  Lin Liu; Shi-Qi Ling; Qiao-Li Li; Tao Wang; Hui Ye; Jie-Zhen Yang; Xiu-Hua Jia
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Proliferative and migratory aptitude in pterygium.

Authors:  Haiqing Bai; Yufei Teng; Lee Wong; Vishal Jhanji; Chi-Pui Pang; Gary Hin-Fai Yam
Journal:  Histochem Cell Biol       Date:  2010-10-12       Impact factor: 4.304

Review 3.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.

Authors:  S Ling; Q Li; H Lin; W Li; T Wang; H Ye; J Yang; X Jia; Y Sun
Journal:  Eye (Lond)       Date:  2012-09-14       Impact factor: 3.775

5.  Relationship between angiogenesis and lymphangiogenesis in recurrent pterygium.

Authors:  Chao-Xiu Qi; Xiao-Dong Zhang; Jin Yuan; Jie-Zhen Yang; Yi Sun; Tao Wang; Hui Ye; Shi-Qi Ling
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

6.  Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Authors:  Erdem Dinç; Özer Dursun; Banu Yılmaz; Mustafa Vatansever; A Ayça Sarı; Özlem Yıldırım; Ufuk Adıgüzel
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

7.  Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin).

Authors:  Noha Ghoz; John Britton; Andrew R Ross; Imran Mohammed; Emily Hogan; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2019-06-19       Impact factor: 3.775

8.  E-cadherin promoter hypermethylation may contribute to protein inactivation in pterygia.

Authors:  Chi-Hsien Young; Yu-Te Chiu; Tung-Sheng Shih; Wan-Ru Lin; Chun-Chi Chiang; Ying-Erh Chou; Ya-Wen Cheng; Yi-Yu Tsai
Journal:  Mol Vis       Date:  2010-06-09       Impact factor: 2.367

9.  Expression of vascular endothelial growth factor C in human pterygium.

Authors:  Junichi Fukuhara; Satoru Kase; Tsutomu Ohashi; Ryo Ando; Zhenyu Dong; Kousuke Noda; Takeshi Ohguchi; Atsuhiro Kanda; Susumu Ishida
Journal:  Histochem Cell Biol       Date:  2012-08-23       Impact factor: 4.304

10.  miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium.

Authors:  David H Engelsvold; Tor P Utheim; Ole K Olstad; Pedro Gonzalez; Jon R Eidet; Torstein Lyberg; Anne-Marie S Trøseid; Darlene A Dartt; Sten Raeder
Journal:  Exp Eye Res       Date:  2013-07-19       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.